(MedPage Today) — This weeks topics include chef-enhanced school meals, diabetic retinopathy treatment, exercise, vitamin D and falls, and stents versus medical therapy for those at risk for a second stroke.
Author: MedPage Today
Another VEGF Drug OK’d for Diabetic Retinopathy
(MedPage Today) — FDA clears aflibercept for diabetic retinopathy in DME patients.
Morning Break: Ocular Syphilis, $25M Criminal Contamination
(MedPage Today) — Health news and commentary from around the Web, gathered by the MedPage Today staff.
Morning Break: LSD and Shrooms Touted for Brain Benefit?
(MedPage Today) — Health news and commentary from around the Web, gathered by the MedPage Today staff.
Tweet of the Week: Addressing the Dress that Went Viral
(MedPage Today) — Science weighs in: Why do people see the dress as different colors?
Morning Break: Appointment With Death; Infectious Hospitals Map
(MedPage Today) — Health news and commentary from around the Web, gathered by the MedPage Today staff.
Anti-VEGF Drugs Boost Vision in Diabetic Eyes (CME/CE)
(MedPage Today) — Relative effects of intravitreous aflibercept, bevacizumab, and ranibizumab depend on baseline visual acuity.
Morning Break: Aggressive HIV; Measles Not Mickey’s Fault
(MedPage Today) — Health news and commentary from around the Web, gathered by the MedPage Today staff.
B-Cell Antibody Modestly Improves Sjogren?s Symptoms (CME/CE)
(MedPage Today) — Study says further randomized, controlled trials needed to gauge effectiveness.
Limited Success With Myelin Rebuilder in Optic Neuritis
(MedPage Today) — Phase II results called “encouraging” though most endpoints missed.
Ankylosing Spondylitis: More Than Just the Spine
(MedPage Today) — The eyes, skin, and bowel all can be affected.
Tweet of the Week: Food for Thought for Those Who Google
(MedPage Today) — Because sometimes it’s fun to step back and see if your current situation would be funny or strange out of context.
Morning Break: Running Toward Youth, Marriage Heartbreak
(MedPage Today) — Health news and commentary from around the Web, gathered by the MedPage Today staff.
Morning Break: Measles Makes a Comeback, Booze Benefits
(MedPage Today) — Health news and commentary from around the Web, gathered by the MedPage Today staff.
The Week Ahead: HCV Takes Center Stage; ASN, ACR, and AHA in the Wings
(MedPage Today) — HCV treatment will again make headlines at the AASLD meeting and MedPage Today drills down with special features on renal cell carcinoma and multiple myeloma the week of Nov. 10.
Make the Diagnosis: Woman can’t roll her right eye
(MedPage Today) — This 36 year-old female presented with blurry
vision. Upon examination she was unable to
adduct her right eye. An MRI demonstrated a
lesion on the optic nerve.
What is the diagnosis?
ACEP: tPA, Chest Pain, Corneal Abrasions (with audio)
(MedPage Today) — Jeremy Faust, MD and Lauren Westafer, MD share some pearls from Wednesday’s session.
PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) — This week’s topics include fecal transplant capsules, stem cells for macular degeneration, exercise and depression in teens, and Ebola predictions.
Embryonic Stem Cell Tx Bolsters Vision
(MedPage Today) — Findings spur optimism not celebration.
FDA Okays Two DME Implants
(MedPage Today) — Alimera and Allergan products offer new treatment options.